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Host genomes have adopted several strategies to curb the proliferation of transposable elements and viruses. A
recently discovered novel primate defense against retroviral infection involves a single-stranded DNA-editing enzyme,
APOBEC3G, that causes hypermutation of HIV. The HIV-encoded virion infectivity factor (Vif) protein targets APOBEC3G
for destruction, setting up a genetic conflict between the APOBEC3G and Vif genes. This kind of conflict leads to rapid
fixation of mutations that alter amino acids at the protein–protein interface, referred to as positive selection. We show
that the APOBEC3G gene has been subject to strong positive selection throughout the history of primate evolution.
Unexpectedly, this selection appears more ancient than, and is likely only partially caused by, modern lentiviruses.
Furthermore, five additional APOBEC genes in the human genome appear to be engaged in similar genetic conflicts,
displaying some of the highest signals for positive selection in the human genome. Despite being only recently
discovered, editing of RNA and DNA may thus represent an ancient form of host defense in primate genomes.
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Introduction
Mobile genetic elements have been in conﬂict with host
genomes for over a billion years. Our own genomes reveal the
remarkable effects of retrotransposition, as about 45% of our
genomic DNA results directly from this process (Lander et al.
2001). This perennial state of conﬂict has led eukaryotes to
adopt several strategies to curb the proliferation of trans-
posable elements and viruses. These include transcriptional
silencing through DNA and histone methylation (Tamaru and
Selker 2001; Selker et al. 2003) or RNA interference (Ketting
et al. 1999; Tabara et al. 1999; Aufsatz et al. 2002), and even
directed mutagenesis of mobile elements (Selker et al. 2003).
Despite facing this gauntlet of defense strategies, trans-
posable elements have thrived in eukaryotic genomes (with
Neurospora crassa being a notable exception [Selker et al.
2003]) by evolving suitable countermeasures. Our current
understanding of the intracellular interplay between host
defenses and the assault of transposable elements suffers
from a paucity of cases where both counterstrategies have
been clearly identiﬁed. This is in contrast to extracellular
cases, where interactions between viral proteins and either
host immune surveillance or host receptors have been well
established. Understanding the nature and evolutionary time-
frame of intracellular conﬂict is key to understanding the
current state of eukaryotic genomes. Recent studies of host
inhibition of HIV have uncovered mutations introduced by
DNA editing as a novel means by which host genomes battle
viruses intracellularly. Furthermore, the means by which
viruses combat this defense strategy are also identiﬁed, thus
providing an unprecedented opportunity to study the
evolution of intracellular genetic conﬂict.
Different human cell lines vary in their susceptibility to
HIV infection. The gene responsible for this differential
susceptibility was identiﬁed as apolipoprotein B–editing catalytic
polypeptide 3G (APOBEC3G) (Sheehy et al. 2002), whose product
targets HIV and simian immunodeﬁciency virus (SIV) for
editing as their genomes undergo reverse transcription in the
cytoplasm of host cells. APOBEC3G is a cytidine deaminase
that edits cytosines to uracils in the minus strand DNA copied
from the viral RNA genome, resulting in promiscuous
guanine-to-adenine (G-to-A) hypermutation of the plus
(protein-coding) strand of the viral DNA (Harris et al. 2003;
Mangeat et al. 2003; Zhang et al. 2003). APOBEC3G is
expressed in testes, ovary, spleen, peripheral blood leuko-
cytes, and T-lymphocytes (Jarmuz et al. 2002; Sheehy et al.
2002) and is packaged in nascent virions and delivered into
new host cells along with the viral genome (Harris et al. 2003).
How this editing reduces the evolutionary ﬁtness of the virus
is not well established. The mutations introduced by the
editing process may either directly reduce viral ﬁtness, or
target the uracil-containing viral DNA for destruction (Gu
and Sundquist 2003). Before the discovery of APOBEC3G,
RNA editing was thought to function solely in the diversiﬁ-
cation of gene-encoded information. The discovery of viral
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APOBEC3G belongs to a family of nine primate genes that
catalyze the deamination of cytosine to uracil in DNA and/or
RNA (Figure 1). Two other members of this family are known
to have important in vivo editing functions. APOBEC1
encodes a protein that site-speciﬁcally edits the mRNA of
apolipoprotein B (APOB), leading to a truncated form of the
APOB lipid-transport protein (Chan et al. 1997), which is
important for determining levels of low-density lipoprotein
production. Another member of this family, activation-
induced deaminase (AID), is important for all steps following
V(D)J recombination in B lymphocytes (Fugmann and Schatz
2002), from generating antibody diversity to class-switching
events. Signiﬁcantly, APOBEC1 and AID act within the
nucleus, whereas APOBEC3G is exclusively cytoplasmic,
which prevents it from mutating ‘‘self’’ DNA molecules.
Whereas rodents have a single APOBEC3 gene, humans have
at least six (Jarmuz et al. 2002), including APOBEC3G. The
functions of the other members of this expanded APOBEC3
cluster are unknown, although APOBEC3C has been shown to
be catalytically active, exhibiting DNA mutator activity in a
bacterial system that is like APOBEC3G (Harris et al. 2002).
More recently, APOBEC3F has also been associated with anti-
HIV biological activity (Wiegand et al. 2004; Zheng et al.
2004).
Most lentiviruses encode an accessory gene, virion infectivity
factor (Vif), whose product counteracts the antiviral activity of
APOBEC3G. Vif interacts with APOBEC3G and targets it for
ubiquitination and proteasome-dependent degradation, thus
preventing its incorporation into nascent virions (Madani
and Kabat 1998; Simon et al. 1998; Marin et al. 2003; Sheehy
et al. 2003; Stopak et al. 2003; Yu et al. 2003). This interaction
can be species-speciﬁc, as the Vif protein of one lentivirus
will counteract APOBEC3G from its host species, but not
always the APOBEC3G from a different primate species
(Mariani et al. 2003). Thus, APOBEC3G and Vif are predicted
to be under selection to decrease and enhance, respectively,
their interaction with one another, each driving rapid change
in the other. Genetic conﬂicts like this one are predicted to
result in the rapid ﬁxation of mutations that alter amino
acids, speciﬁcally those that affect this protein–protein
interaction. This scenario is referred to as positive selection
and is commonly seen in host–pathogen interactions.
In this report, we directly test this prediction by studying
the paleontology of selective pressures that have acted on
APOBEC3G in the primate lineage, to ask whether APOBEC3G
has been subject to positive selection, and to date the origins
of this genetic conﬂict. We ﬁnd that APOBEC3G has been
under remarkably strong positive selection, and has under-
gone several episodes of adaptive evolution throughout the
history of primates. Unexpectedly, we ﬁnd that the positive
selection acting on APOBEC3G predates modern lentiviruses,
indicating that a more ancient, and perhaps ongoing, conﬂict
has shaped its evolution. We also report evidence for strong
positive selection acting on a majority of the APOBEC genes,
suggesting that this family of genes may have expanded in
primate genomes for genome defense via RNA/DNA editing.
Results/Discussion
APOBEC3G Has Been Evolving under Positive Selection in
Primates
To determine what selective pressures have shaped
APOBEC3G evolution, we sequenced the APOBEC3G gene
from a panel of primate genomes representing 33 million
years of evolution. We sequenced the complete APOBEC3G
coding sequence (approximately 1,155 bp) from ten primate
species, including four hominids (other than human), four
Old World monkeys (OWMs), and two New World monkeys
Figure 1. The Primate APOBEC Family
(A) The human genome contains nine known members of the
APOBEC family. AID and APOBEC1 are located approximately 900 kb
apart on human Chromosome 12. The primate-speciﬁc APOBEC3
cluster of six genes resides on human Chromosome 22, and likely
arose through a series of gene duplication events (Jarmuz et al. 2002;
Wedekind et al. 2003). The single APOBEC3-like gene found in mouse
resides on Chromosome 15 (not shown), which is syntenic to human
Chromosome 22 (Sheehy et al. 2002). There is EST evidence for both
APOBEC3D and APOBEC3DE (see Materials and Methods), and we
treat these as three separate transcripts in our analysis because
currently there is no evidence for the relevant protein products.
(B) All members of the APOBEC family contain an active site that
encodes a zinc-dependent cytidine deaminase domain with the HXE,
PCXXC signature (Mian et al. 1998), a linker peptide, and a
pseudoactive domain (Navaratnam et al. 1998; Jarmuz et al. 2002).
The active and pseudoactive domains are related by structure only,
and likely originated from a gene duplication event followed by
degeneration of the catalytic activity of the pseudoactive domain.
Several members of the human APOBEC3 gene cluster (APOBEC3B,
3DE, 3F, and 3G) have undergone an additional duplication/
recombination event and now contain two each of the active and
pseudoactive sites (Jarmuz et al. 2002; Wedekind et al. 2003), as does
the single APOBEC3-like gene found in mouse.
DOI:10.1371/journal.pbio.0020275.g001
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Immunity Promotes Virulence Evolution(NWMs) (Figure 2). A phylogeny constructed using either
complete APOBEC3G sequences or individual exons (unpub-
lished data) is congruent to the widely accepted primate
phylogeny (Purvis 1995), indicating that all sequences isolated
by our PCR strategy are truly orthologous.
The hallmark of positive selection is an excess of non-
synonymous substitutions (which alter the amino acid being
encoded) relative to synonymous substitutions (which retain
the encoded amino acid). Because non-synonymous changes
are more likely to be deleterious, they are typically culled out
by selection (Hurst 2002) (referred to as purifying or negative
selection). Therefore, in protein-coding open reading frames,
the number of observed changes per synonymous site (Ks)
usually exceeds the number of observed changes per non-
synonymous site (Ka). In the case of the APOBEC3G, however,
we found that a majority of branches of the phylogeny
(including internal branches) show evidence of positive
selection (deﬁned as Ka/Ks [x] greater than one; see Figure
2). This implies that the APOBEC3G has been subject to
positive selection throughout the history of primate evolu-
tion. In support of this conclusion, all pairwise comparisons
of the entire APOBEC3G gene between the various primates
have x greater than one (unpublished data). Maximum
likelihood analysis using the PAML (phylogenetic analysis by
maximum likelihood) suite of programs also ﬁnds strong
evidence that the full-length APOBEC3G gene has been
subject to positive selection (p , 10
–13). Numbers in paren-
thesis in Figure 2 indicate the actual number of non-
synonymous and synonymous changes (R:S) that have
occurred along each branch.
The average Ks in APOBEC3G is not unusually low; it is
about 0.09 between hominids and OWMs and 0.26 between
hominids and NWMs, compared to 0.08 and 0.15 respectively
for comparisons of various intronic and noncoding regions of
primate genomes (Li 1997). Thus, we can rule out the
possibility that selection has led to deﬂated Ks values in
APOBEC3G that lead to artiﬁcially high x ratios. Indeed, these
high x ratios can be explained only by a signiﬁcantly higher
rate of non-synonymous substitutions. Of the primates
analyzed, lentiviral infections have been observed only in
the African monkeys, chimpanzees, and humans (Peeters and
Courgnaud 2002). HIV/SIV-infected species are indicated
with asterisks in Figure 2. Estimating the age of lentiviruses is
difﬁcult because of their rapid rate of evolution and frequent
cross-species transfer, but it has been suggested that primate
lentiviruses are no older than 1 million years (Sharp et al.
1999). The presence of modern lentiviruses appears to bear
no correlation to either the presence or the strength of
positive selection. For instance, the lineage leading to
hominids has a x of 3.3, the highest overall. The positive
selection acting on APOBEC3G thus appears to predate
modern lentiviruses, and interactions with lentiviral Vif
proteins are not likely to be a major cause of this unusually
strong signal of positive selection. In support of this
conclusion, HIV has not been in the human population long
enough to account for the positive selection of APOBEC3G
speciﬁc to the human lineage (a 7:0 R:S ratio) arguing that,
although the positive selection of Vif may be explained in
large part by that of APOBEC3G, the reverse is certainly not
the case.
Positive Selection in APOBEC3G Is Not Localized to One
Domain
We wanted to identify the speciﬁc domains in APOBEC3G
that were subject to positive selection, because this might
suggest the driving evolutionary force. For instance, the
positive selection in the major histocompatibility complex
proteins is conﬁned to only small segments of the protein
that constitute the antigen-recognition site (Hughes and Nei
1988; Yang and Swanson 2002), because only these sites
participate in protein–protein interactions subject to genetic
conﬂict. All members of the APOBEC family contain a similar
domain organization (see Figure 1B) that consists of an active
site that encodes a zinc-dependent cytidine deaminase
domain with the HXE, PCXXC (H, histidine; X, any amino
acid; E, glutamic acid; P, proline; C, cysteine) signature (Mian
Figure 2. APOBEC3G Has Been Under
Positive Selection for at Least 33 Million
Years
The x values and actual numbers of non-
synonymous and synonymous changes
(R:S, included in parentheses) in APO-
BEC3G are indicated on the accepted
primate phylogeny (Purvis 1995) that
includes ﬁve hominids, ﬁve OWMs, and
two NWMs. OWMs diverged from hom-
inids about 23 million years ago, whereas
NWMs diverged around 33 million years
ago (Nei and Glazko 2002). x values were
calculated using the PAML package of
programs using the free-ratio model that
allows x to vary along each branch. In
some instances, zero synonymous sub-
stitutions lead to an apparent x of
inﬁnity. HIV/SIV-infected species are
indicated by asterisks.
DOI:10.1371/journal.pbio.0020275.g002
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(Navaratnam et al. 1998; Jarmuz et al. 2002). The active and
pseudoactive domains are believed to have originated from a
gene duplication event followed by degeneration of the
catalytic activity of the pseudoactive domain. APOBEC3G and
some other APOBEC genes have also undergone a second
gene duplication/fusion event (Jarmuz et al. 2002; Wedekind
et al. 2003).
Representative examples of pairwise (sliding window)
comparisons of Ka/Ks ratios between two hominids, two
OWMs, and two NWMs suggest that the same domain of
APOBEC3G has not been subject to positive selection
throughout primate evolution (Figure 3A–3C). In both the
hominid and NWM comparisons, the second half of the gene
shows evidence of positive selection (Figure 3A and 3C), but
in an OWM comparison, it is the ﬁrst half that is under
positive selection (Figure 3B). When the APOBEC3G gene is
divided into structural domains, we ﬁnd that all domains,
including the active site domains, have undergone multiple
distinct episodes of positive selection (Figure S1). This highly
unusual pattern suggests that the genetic conﬂicts that have
shaped APOBEC3G evolution have involved episodic pro-
tein–protein interactions with different parts of the entire
APOBEC3G protein.
We also employed a maximum-likelihood approach (see
Materials and Methods), using the PAML suite of programs
(Yang 1997) to identify the speciﬁc residues that have been
repeatedly subject to positive selection in primates. These
analyses (in the best ﬁt model) identify 30% of the codons as
having evolved under stringent purifying selection (x of
approximately zero). These include the catalytically impor-
tant residues that are invariant throughout all APOBECs. The
same analysis also identiﬁes approximately 30% of the
codons as having evolved under positive selection with an
average x of nearly 3.5 (residues that are evolving without
selective constraint would be expected to have an average x
of one). Even among adaptively evolving proteins, this is an
unusually high proportion of sites, once again implicating a
large number of residues in APOBEC3G as having partici-
pated in some kind of genetic conﬂict. Of these, several
residues are identiﬁed as being under positive selection with
high conﬁdence (posterior probability greater than 0.95,
inverted triangles in Figure 3D). In simulations using datasets
with comparable levels of sequence divergence and strength
of positive selection to our APOBEC3G dataset (tree length =
1.59), PAML analyses were found to be highly accurate in
identifying residues subject to positive selection (Anisimova
et al. 2002).
The schematic in Figure 3D highlights the region where Vif
is believed to interact with human APOBEC3G (Conticello et
al. 2003). It also highlights the single amino acid residue (cross
symbol in linker 1) that is responsible for the species-speciﬁc
interactions seen between Vif and APOBEC3G in African
green monkeys (SIV) and humans (HIV) (Bogerd et al. 2004;
Schrofelbauer et al. 2004). There is a noticeable lack of
correlation between the sites on APOBEC3G that are
important for Vif interaction and those sites that are
identiﬁed by PAML with high conﬁdence, supporting our
earlier conclusion that Vif interactions have played only a
small role in dictating the positive selection of APOBEC3G.
Other APOBEC Genes May Participate in Host Defense
The discovery that APOBEC3G is involved in host defense
was predicated on the tissue-speciﬁc inhibition of HIV. Other
studies have investigated a possible inhibitory role of other
APOBEC genes but found that only APOBEC3G and APO-
Figure 3. Episodic Positive Selection on
Different Regions of the APOBEC3G Gene
(A–C) Sliding window (300-bp window;
50-bp slide) analysis of Ka and Ks was
performed on three representative pairs
of primate APOBEC3G sequences, be-
tween two hominids (human–orangutan)
(A), between two OWMs (crested ma-
caque–baboon) (B), and between two
NWMs (tamarin–woolly monkey) (C).
Ka/Ks, Ka, and Ks are plotted against
the length of the gene (with a schematic
of protein domains along the x-axis) to
illustrate that different domains of APO-
BEC3G have undergone positive selec-
tion, depending on which lineage is
examined. The value for x, indicated by
Ka/Ks, is not shown for part of the
crested macaque–baboon comparison
(B), because Ks is zero in this region
(see plot below).
(D) A schematic of the domains of
human APOBEC3G illustrates the N-
terminal domain (aa 1–29), the two
active sites (aa 30–120 and 215–311), and the pseudoactive sites (aa 162–214 and 348–384). Also illustrated is the Vif-interaction domain of
APOBEC3G (aa 54–124) (Conticello et al. 2003) as well as the single amino acid residue responsible for species-speciﬁc sensitivity to Vif (aspartic
acid 128; cross shape in linker 1) (Bogerd et al. 2004; Schrofelbauer et al. 2004). PAML (Yang 1997) was used to identify individual residues
(codons) that have signiﬁcant posterior probabilities of x greater than 1.0 (see Materials and Methods). Those codons with posterior probabilities
greater than 0.95 and greater than 0.99 are indicated by open and closed inverted triangles, respectively (listed in Figures S2 and S3). This
represents only a subset of the residues that are likely to be under positive selection, highlighting those residues that have repeatedly undergone
non-synonymous substitutions. For instance, residue 128 is not highlighted, as it has a posterior probability of only 0.55 because it has undergone
only one ﬁxed non-synonymous change (along the OWM lineage). Domains have been deﬁned by protein sequence alignment to APOBEC1
(Jarmuz et al. 2002). The ﬁrst pseudoactive domain is likely to include in its C-terminus a second duplication of the N-terminal domain, although
this boundary cannot be resolved because of sequence divergence.
DOI:10.1371/journal.pbio.0020275.g003
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2003; Wiegand et al. 2004; Zheng et al. 2004). An unbiased
look at selective pressures among other APOBEC genes could
reveal clues to their function. We calculated whole-gene Ka/
Ks ratios for other members of the human APOBEC family,
using orthologs from the chimpanzee genome project (Table
1, second column). This analysis reveals strong evidence of
purifying selection acting on AID and APOBEC3A but positive
selection acting on APOBEC3B and APOBEC3DE (as well as
APOBEC3D and APOBEC3E alone) in addition to APOBEC3G.
There is no expression evidence for APOBEC3E, and it is
unclear whether it occurs as a stand-alone gene, but its x
ratio of 5.6 is among the highest seen for any human–chimp
comparison and argues strongly that it is a functional gene
and an active participant in some form of genetic conﬂict.
Whole-gene analyses are notoriously poor at identifying
speciﬁc domains of positive selection, especially when the
rest of the gene is subject to purifying selection. We therefore
performed a sliding window Ka/Ks test (Endo et al. 1996),
which also reveals positive selection acting on APOBEC3F
(amino acids [aa] 117–250).
The limited divergence between human and chimp
genomes leads to some comparisons not being informative
enough to detect selection (APOBEC1 and APOBEC3C), and
there was insufﬁcient chimpanzee sequence available in one
case (APOBEC2). To gain further information about these
genes, we sequenced them from either orangutan or gorilla
(Table 1, third column). These comparisons reveal that strong
purifying selection has acted on APOBEC2, but positive
selection can be detected in both APOBEC1 (aa 1–100; also
see Figure 4) and APOBEC3C (aa 34–133). Although we might
have expected APOBEC1 to be evolving only under purifying
selection based on its important editing of APOB mRNA, our
analysis suggests that APOBEC1 has also participated in some
kind of genetic conﬂict involving its ﬁrst active site, and
suggests that the rapid evolution of APOBEC1 seen previously
in mouse–rat comparisons may also be due to positive
selection (Nakamuta et al. 1995). Figure 4 shows representa-
tive sliding window analyses of genes undergoing gene-wide
purifying (APOBEC2) and positive (APOBEC3E) selection.
These ﬁndings greatly extend the current understanding of
the APOBEC family, and implicate a majority of APOBEC
Table 1. Positive Selection throughout the APOBEC3 Gene Cluster
Gene Human–Chimp
(x)
Human–Other Primates
(x)
Protein Size
(Amino Acids)
Selection Site of Expression
APOBEC1 1.6 0.41 ** (orangutan)
(for aa 1–100, x = 2.4 **)
236 Positive (window) Small intestine (Lau et al.
1994)
APOBEC2 N.D. 0.35 * (orangutan) 224 Purifying Heart, skeletal muscle
(Liao et al. 1999)
AID 0.13 ** N.D. 193 Purifying Activated B cells
(Muramatsu et al. 1999)
APOBEC3A
a 0.32 * N.D. 199 Purifying
APOBEC3B
b 1.8 * N.D. 382 Positive Peripheral blood leuko-
cytes (Jarmuz et al. 2002)
APOBEC3C 1.6 0.86 (gorilla) (for aa
34–133, x = 2.3 *)
190 Positive (window) Spleen, testes, heart, thy-
mus, prostate, ovary, pe-
ripheral blood leukocytes
(Jarmuz et al. 2002)
APOBEC3D
c 1.8 * N.D. 201 Positive
APOBEC3E
d 5.6 *** N.D. 185 Positive
APOBEC3DE
e 2.6 *** N.D. 386 Positive None observed (Jarmuz et
al. 2002)
APOBEC3F 1.3 (for aa 117–250,
x = 3.2 ***)
N.D. 362 Positive (window) None observed (Jarmuz et
al. 2002)
APOBEC3G 2.3 ** N.D. 384 Positive Spleen, testes, ovary, pe-
ripheral blood leukocytes
(Jarmuz et al. 2002)
* p , 0.05; ** p , 0.01; *** p , 0.001
a189 out of 200 amino acids analyzed in human–chimp comparison
b376 out of 383 amino acids analyzed in human–chimp comparison
c196 out of 202 amino acids analyzed in human–chimp comparison
d119 out of 186 amino acids analyzed in human–chimp comparison
e314 out of 387 amino acids analyzed in human–chimp comparison
N.D., not determined
x ratios were calculated for human–chimp orthologs, and tested against the neutral expectation that x =1( p-values obtained from simulations performed in K-estimator).
Values of x significantly less and greater than one imply purifying and positive/diversifying selection, respectively. We were unable to obtain enough APOBEC2 sequence
from the chimpanzee genome project to do this analysis, so APOBEC2 was sequenced from orangutan. When sliding window analysis was performed, APOBEC1 (human–
orangutan; see Figure 4), APOBEC3C (human–gorilla), and APOBEC3F (human–chimp) show regions of both significant positive and purifying selection. Windows of positive
selection in these genes are indicated as amino acid ranges (e.g., aa 1–100 for APOBEC1) along with the associated x values and statistical significance.
DOI:10.1371/journal.pbio.0020275.t001
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possibility of other editing systems being involved in genome
defense; for instance, hepatitis delta virus is known to be
edited by adenosine deaminase (Polson et al. 1996).
Human APOBEC3G Polymorphisms and AIDS
The antiviral activity of APOBEC3G and the excess of non-
synonymous changes speciﬁc to human APOBEC3G (see
Figure 2) implicate non-synonymous polymorphisms as being
functionally very important. Because binding by Vif inhibits
APOBEC3G’s antiviral ability, we might predict that APO-
BEC3G should be subject to overdominant selection (hetero-
zygous individuals being at a selective advantage), especially
in populations with a high incidence of HIV infection, since
different alleles of APOBEC3G may have different suscepti-
bility to various viral strains. The action of APOBEC3G on
viral evolution could also be complex because, although it is
ineffective as an antiviral mechanism in the presence of Vif,
its action could also result in an increased likelihood of
adaptive changes and viral diversity in the host due to the
introduced G-to-A hypermutations. Polymorphisms in APO-
BEC3G may thus have direct impact on the progression time
from initial HIV infection to AIDS, and should be inves-
tigated as such.
What Drives the Long-Term Evolution of APOBEC3G?
The evidence for positive selection of APOBEC3G does not
identify the biological step that exerts this selective pressure.
Formally, this step could be the yet-undeﬁned mechanism by
which APOBEC3G is packaged into virions, the interaction of
APOBEC3G with Vif-like destruction proteins encoded by
other viruses, and/or its interaction with the proteasome
machinery. APOBEC3G may indeed interact with other
viruses, because G-to-A hypermutation—a hallmark of the
single-stranded DNA–editing activity of APOBEC3G-like
enzymes—has been observed in some nonlentivirus viruses
(Vartanian et al. 2003), and because APOBEC3G has recently
been shown to inhibit the replication of the hepatitis B virus
upon deliberate coexpression (Turelli et al. 2004). However,
this inhibition of hepatitis B is not correlated with G-to-A
hypermutation, suggesting that APOBEC3G may also inhibit
viral replication independent of its catalytic activity.
The ancient, constant pressure of positive selection on
APOBEC3G in primates raises the possibility that at least some
of its evolution may be explained by a struggle not in the
lymphocytes, but in the germline, where APOBEC3G is also
abundantly expressed (Jarmuz et al. 2002), and where
genome-restricted mobile genetic elements need to transpose
to ensure survival. Of the three main classes of eukaryotic
mobile elements, only two are active in humans and, most
likely, other primate genomes. The ﬁrst and major class
includes the LINE1 (long interspersed element–1) non-LTR
(long terminal repeat) retroposons that are not a likely target
for APOBEC3G, because they carry out their reverse tran-
scription in the nucleus (APOBEC3G is restricted to the
cytoplasm). A second class, the LTR-bearing human endog-
enous retroviruses (HERVs), is identical in many aspects of its
life cycle to retroviruses. While the selective disadvantage to
an individual organism conferred by endogenous retroviruses
may pale in comparison to that of pathogenic viruses, over
time the steady retrotransposition of endogenous retrovi-
ruses is likely to be more detrimental to a species than
scattered, episodic interactions with viruses. Thus, the
constant efforts of HERVs to jockey for evolutionary
dominance may provide a more likely explanation for the
positive selection of APOBEC3G and other APOBEC genes in
primate genomes.
Materials and Methods
Genomic DNA sequencing of primate samples. Genomic DNA was
obtained from Coriell (Camden, New Jersey, United States). Species
and Coriell repository numbers are: Pan troglodytes (chimpanzee)
(NAO3448A), Pan paniscus (bonobo) (NGO5253), Gorilla gorilla (gorilla)
(NG05251B), Pongo pygmaeus (orangutan) (NAO4272), Macaca nigra
(Celebes crested macaque) (NG07101), Macaca fascicularis (crab-eating
macaque) (NA03446), Erythrocebus patas (patas monkey) (NG06254),
Lagothrix lagotricha (common woolly monkey) (NG05356), and Saguinus
labiatus (red-chested mustached tamarin) (NG05308). Papio anubis
(baboon) DNA was a personal gift from Dr. Trent Colbert. The
APOBEC3G, APOBEC1, APOBEC2, and APOBEC3C genes were ampli-
ﬁed exon-by-exon from genomic DNA with PCR Supermix High
Fidelity (Invitrogen, Carlsbad, California, United States), and PCR
products were sequenced directly. PCR and sequencing primers are
shown in Table S1. The human APOBEC3G sequence was obtained
from the Ensembl database of the human genome project
(ENSG00000100289). The Chlorocebus aethiops (African green monkey)
APOBEC3G sequence (GenBank AY331714.1) is missing the last 21 bp
of the coding sequence because it was sequenced from mRNA
(Mariani et al. 2003) in a previous study. Exon–intron boundaries are
conserved, except in APOBEC3G from NWMs (woolly monkey and
tamarin) where the ‘‘AG’’ directly 59 of the eighth coding exon is
missing. Sequences have been deposited in GenBank under the
Figure 4. Selective Pressures on APOBEC1,
APOBEC2, and APOBEC3E
Sliding window analysis (250-bp window;
50-bp slide) was performed on three
APOBEC genes. Although APOBEC1 dem-
onstrates purifying selection when the
whole gene is analyzed (Table 1), the
sliding window analysis of a human–
orangutan comparison reveals a window
(aa 1–100) in the ﬁrst active site (dark gray
bar), which shows evidence of positive
selection (p , 0.01). Sliding window
analysis of APOBEC2, which is also
evolving under purifying selection (Table
1), does not show any windows where x is
greater than one. APOBEC3E, which gives
the strongest signal for positive selection
(Table 1), has x greater than one for
almost all windows. (Note that x is not
plotted where Ks = 0).
DOI:10.1371/journal.pbio.0020275.g004
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APOBEC3C (AY622594–AY622597), APOBEC2 (AY622598–
AY622599), APOBEC1 (AY622600–AY622604).
Sequences of other APOBEC family members. Human sequences
were obtained from the Ensembl or GenBank databases: APOBEC1
(ENSG00000111701), APOBEC2 (ENSG00000124701), AID
(ENSG00000111732), APOBEC3A (ENSG00000128383), APOBEC3B
(NM_004900.3), APOBEC3C (ENSG00000179750), APOBEC3DE
(ENSG00000179007), and APOBEC3F (ENSG00000128394). Tran-
scripts for both APOBEC3D (NM_152426) and APOBEC3DE
(BC017022.1) exist in the database. Chimp sequences were obtained
from orthology to human genes assigned on the University of
California at Santa Cruz Genome Bioinformatics Website (http://
www.genome.ucsc.edu). All orthologous chimp exons were checked
for AG and GT ﬂanking the 59 and 39 boundaries, respectively, an
indication that human splice sites are conserved. The mouse
APOBEC3 protein sequence can be found in GenBank
(NP_084531.1).
Sequence analysis. DNA sequences were aligned using Clustal_X
(Thompson et al. 1997), with hand alignment of small indels based on
amino acid sequence. Changes along each lineage (see Figure 2) were
assigned using parsimony and counted by hand. Changes at 18
positions could not be unambiguously assigned as non-synonymous
or synonymous and were excluded from the R:S ratios. Ka and Ks for
pairwise comparisons (Figures 3A–3C and 4; Table 1), as well as their
conﬁdence values, were calculated using the K-estimator software
package (Comeron 1999). For conﬁdence values, simulations were
carried out under the condition where Ka equals Ks and compared to
actual Ka from that region, and multiple parameters for transition:
transversion ratios were simulated.
Maximum likelihood analysis was performed with the PAML
software package (Yang 1997). Global x ratios for the tree (see Figure
2) were calculated by a free-ratio model, which allows x to vary along
different branches. To detect selection, the multiple alignments were
ﬁtted to either the F334 or F61 models of codon frequencies. We then
compared the log-likelihood ratios of the data using different NSsites
models: model 1 (two-state, neutral, x . 1 disallowed) to model 2
(similar to model 1 but x .1 allowed), and model 7 (ﬁt to a beta
distribution, x . 1 disallowed) to model 8 (similar to model 7 but x
.1 allowed). In both cases, permitting sites to evolve under positive
selection gave a much better ﬁt to the data (p , 10
13) with a
signiﬁcant fraction of the sites (more than 30%) predicted to evolve
at average x ratios greater than 3.5 (see Figure S2 for details). These
analyses also identiﬁed certain amino acid residues with high
posterior probabilities (greater than 0.95) of having evolved under
positive selection (Figures 3D and S2).
Supporting Information
Figure S1. Episodic Evolution of APOBEC3G Protein Domains
The evolutionary history of APOBEC3G is represented. R:S ratios
are indicated along each branch of the primate cladogram. The
N-terminal domain (A) has undergone adaptive evolution in at
least three distinct periods. Despite being only 29 codons long,
this domain has accumulated ten non-synonymous changes and
only two synonymous changes in the African green monkey since
it and the patas monkey last shared a common ancestor.
Similarly, the orangutan has retained eight non-synonymous
changes and no synonymous changes since it split from the rest
of the hominids. Finally, a ratio of 6:0 R:S changes is seen in the
split between the NWMs and the common ancestor of OWMs and
hominids. Surprisingly, even the two active site structures of
APOBEC3G (B and E) show evidence for adaptive evolution
(despite all the putative catalytic residues being conserved),
including along the branch leading to the common ancestor of
all hominids. The ﬁrst pseudoactive domain (D) acquired ten non-
synonymous and no synonymous changes since the hominids split
from the OWMs.
Found at DOI: 10.1371/journal.pbio.0020275.sg001 (343 KB PDF).
Figure S2. PAML Analysis of APOBEC3G
Maximum likelihood analysis was performed on APOBEC3G sequen-
ces using the PAML software package. To detect selection, the
multiple alignments were ﬁtted to either the F334 (A) or F61 (B)
models of codon frequencies. We compared the log-likelihood ratios
of the data using comparisons of different NSsites models: model 1
(two-state, neutral, x . 1 disallowed) versus model 2 (similar to model
1 but x . 1 allowed) and model 7 (ﬁt to a beta distribution, x . 1
disallowed) versus model 8 (similar to model 7 but x . 1 allowed). In
both cases, permitting sites to evolve under positive selection gave a
much better ﬁt to the data (p ,10
13) (C) with a signiﬁcant fraction of
the sites (more than 30%) predicted to evolve at average x ratios
greater than 3.5. These analyses also identiﬁed certain amino acid
residues with high posterior probabilities (greater than 0.95) of
having evolved under positive selection (A and B).
Found at DOI: 10.1371/journal.pbio.0020275.sg002 (60KB PDF).
Figure S3. Alignment of APOBEC3G Protein Sequences
The individual domains of the APOBEC3G protein are demarcated.
Catalytically important residues are highlighted in bold, and those
residues identiﬁed by PAML analysis as being under positive selection
are indicated with gray shading. Blue shading highlights the single
amino acid residue that can switch speciﬁcity of Vif interaction with
APOBEC3G. AGM, African green monkey.
Found at DOI: 10.1371/journal.pbio.0020275.sg003 (46 KB PDF).
Table S1. Complete List of Primers Used in This Study
Found at DOI: 10.1371/journal.pbio.0020275.st001 (39 KB PDF).
Accession numbers
The GenBank (http://www.ncbi.nlm.nih.gov/) and Ensembl (http://
www.ensembl.org/) accession numbers for the genes and gene
products discussed in this paper are as follows. GenBank: APOBEC1
(AY622600–AY622604), APOBEC2 (AY622598–AY622599), mouse
APOBEC3 (NP_084531.1), human APOBEC3B (NM_004900.3), APO-
BEC3C (AY622594–AY622597), APOBEC3D (NM_152426), APO-
BEC3DE (BC017022.1), APOBEC3G (AY622514–AY622593), and
African green monkey APOBEC3G (AY331714.1). Ensembl (all human
sequences): APOBEC1 (ENSG00000111701), APOBEC2
(ENSG00000124701), AID (ENSG00000111732), APOBEC3A
(ENSG00000128383), APOBEC3C (ENSG00000179750), APOBEC3DE
(ENSG00000179007), APOBEC3F (ENSG00000128394), and APO-
BEC3G (ENSG00000100289).
Coriell (http://www.coriell.undmj.edu/) repository numbers for
primate genomic DNAs are Pan troglodytes (chimpanzee) (NAO3448A),
Pan paniscus (bonobo) (NGO5253), Gorilla gorilla (gorilla) (NG05251B),
Pongo pygmaeus (orangutan) (NAO4272), Macaca nigra (Celebes crested
macaque) (NG07101), Macaca fascicularis (long-tailed macaque)
(NA03446), Erythrocebus patas (patas monkey) (NG06254), Lagothrix
lagotricha (common woolly monkey) (NG05356), and Saguinus labiatus
(red-chested mustached tamarin) (NG05308).
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